Copyright
        ©The Author(s) 2015.
    
    
        World J Gastroenterol. Apr 28, 2015; 21(16): 4925-4932
Published online Apr 28, 2015. doi: 10.3748/wjg.v21.i16.4925
Published online Apr 28, 2015. doi: 10.3748/wjg.v21.i16.4925
            Table 1 Clinical data of patients with hepatobiliary complications of alveolar echinococcosis
        
    | Characteristic | Frequency | 
| Symptoms1 | |
| Jaundice | 54.3% | 
| Abdominal pain | 31.4% | 
| Weight loss | 20.0% | 
| Indication for intervention1 | |
| Cholestasis | 54.3% | 
| Jaundice | 25.7% | 
| Stenosis of biliary tract | 17.1% | 
| Cholangitis | 11.4% | 
| Intervention method1 | |
| ERCP + stent replacement | 82.9% | 
| PTCD | 31.4% | 
| ERCP without stent replacement | 22.9% | 
| MRCP | 14.3% | 
| Additional procedures1 | |
| Papillotomy | 68.8% | 
| Dilatation of the bile ducts | 50.0% | 
| Gallstone extraction | 25.0% | 
| Types of stents | |
| Plastic stent | 30.8% | 
| Pigtail drainage | 7.7% | 
| Metal stent | 3.9% | 
| Percutaneous drainage | 3.9% | 
| Transhepatic jejunal endless drainage | 3.9% | 
| No data | 50.0% | 
            Table 2 Hepatic function parameters in six patients with alveolar echinococcosis with hepatobiliary complications and intervention
        
    | Parameter | First diagnosis | Intervention | Post-intervention | 
| ALT, U/L | 109.0 ± 64.3 | 169.0 ± 87.4 | 118.5 ± 154.9 | 
| AST, U/L | 72.7 ± 50.0 | 108.7 ± 41.9 | 66.7 ± 50.0 | 
| GGT, U/L | 301.3 ± 237.3 | 393.3 ± 242.3 | 227.3 ± 117.7 | 
| AP, U/L | 272.3 ± 134.8 | 300.3 ± 75.5 | 246.5 ± 95.5 | 
| Bilirubin, mmol/L | 101.3 ± 164.8 | 147.1 ± 154.2 | 83.6 ± 89.8 | 
            Table 3 Hepatic function parameters in patients with and without hepatobiliary complications of alveolar echinococcosis and subsequent intervention at time of first diagnosis
        
    | Parameter | Hepatobiliary complications | P value | |
| No (n = 148) | Yes (n = 24) | ||
| ALT, U/L | 43.2 ± 73.6 | 59.8 ± 48.7 | 0.0035 | 
| AST, U/L | 29.3 ± 35.4 | 41.4 ± 35.5 | 0.0431 | 
| GGT, U/L | 94.4 ± 133.2 | 186.4 ± 194.1 | 0.0005 | 
| AP, U/L | 123.8 ± 88.6 | 200.3 ± 125.5 | 0.0016 | 
| Bilirubin, mmol/L | 9.8 ± 6.2 | 36.5 ± 86.7 | 0.0148 | 
            Table 4 Type of complications
        
    | Complication | Frequency | 
| During first intervention | |
| Failure visualize bile ducts | 66.7% | 
| Bleeding at the papilla of vater | 16.7% | 
| Bile leakage | 16.7% | 
| Within first week after intervention1 | |
| Pancreatitis | 41.7% | 
| Cholangitis | 33.3% | 
| Hemorrhage | 8.3% | 
| Wound infection | 8.3% | 
| Fistula formation | 8.3% | 
| Bacteremia | 8.3% | 
| Abdominal pain | 8.3% | 
| Abscess information | 8.3% | 
| Pneumoperitoneum | 8.3% | 
- Citation: Graeter T, Ehing F, Oeztuerk S, Mason RA, Haenle MM, Kratzer W, Seufferlein T, Gruener B. Hepatobiliary complications of alveolar echinococcosis: A long-term follow-up study. World J Gastroenterol 2015; 21(16): 4925-4932
- URL: https://www.wjgnet.com/1007-9327/full/v21/i16/4925.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i16.4925

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        